Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1996
08/15/1996CA2210955A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
08/15/1996CA2210953A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
08/15/1996CA2210685A1 Human pancreatic cell lines: developments and uses
08/15/1996CA2210664A1 Calcitonin salmon analogues, their preparation, medicinal use and use as analytical agents
08/15/1996CA2210471A1 Human chemokine beta-11 and human chemokine alpha-1
08/14/1996EP0726315A1 Epstein-Barr virus DNA sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests
08/14/1996EP0726314A1 FIMBRILLIN PROTEIN OF $i(PORPHYROMONAS GINGIVALIS)
08/14/1996EP0726313A2 DNA coding for mammalian L-asparaginase
08/14/1996EP0726311A1 Human activated protein c preparation and process for producing the same
08/14/1996EP0726276A1 PEPTIDE CONTAINING AMINO ACID SEQUENCE OF FIMBRIAL PROTEIN OF $i(PORPHYROMONAS GINGIVALIS) AND USE THEREOF
08/14/1996EP0726274A2 G-cap stabilized oligonucleotides
08/14/1996EP0726076A1 Method of stabilizing protein c or activated protein c and stabilized composition
08/14/1996EP0726075A1 Pharmaceutical non-inorganic saline solutions for endonasal administration
08/14/1996EP0726062A2 Center dispense suture package
08/14/1996EP0725838A1 Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics
08/14/1996EP0725830A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof
08/14/1996EP0725828A1 Methods relating to ir-95
08/14/1996EP0725826A1 Improvements relating to cancer therapy
08/14/1996EP0725825A1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
08/14/1996EP0725823A1 A NEW RIBOSOME-INACTIVATING PROTEIN ISOLATED FROM THE PLANT $i(BRYONIA DIOICA)
08/14/1996EP0725819A1 A method for detection of alterations in the dna mismatch repair pathway
08/14/1996EP0725799A1 A novel tumor marker and novel method of isolating same
08/14/1996EP0725798A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas
08/14/1996EP0725797A1 Bivalent thrombin inhibitors
08/14/1996EP0725796A1 Growth differentiation factor-10
08/14/1996EP0725795A1 Single-chain forms of the glycoprotein hormone quartet
08/14/1996EP0725794A1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives
08/14/1996EP0725792A1 RECOMBINANT PilC PROTEINS, PROCESS FOR PRODUCING THEM AND THEIR USE
08/14/1996EP0725791A1 Recombinant p53 adenovirus methods and compositions
08/14/1996EP0725790A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
08/14/1996EP0725788A1 2'-amido and 2'-peptido modified oligonucleotides
08/14/1996EP0725786A1 Novel salts of amino glycosides
08/14/1996EP0725655A1 Platelet-specific chimeric immunoglobulin and methods of use therefor
08/14/1996EP0725654A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
08/14/1996EP0725652A1 METHOD OF TREATING SEPTIC SHOCK USING THYMOSIN $g(b) 4?
08/14/1996EP0725651A1 Hemoregulatory peptides
08/14/1996EP0725650A1 Inhibitors of farnesyl-protein transferase
08/14/1996EP0725649A1 Class i mhc modulation of surface receptor activity
08/14/1996EP0725648A1 Hepatoselective pharmaceutical actives
08/14/1996EP0725647A1 Using lectins for contraception, prophylaxis and therapy
08/14/1996EP0725645A1 COMPOSITIONS FOR USE IN THE REGULATION OF SUBNORMAL pH VALUES IN THE INTESTINAL TRACT AND FOR TREATMENT OF BOWEL DISEASES
08/14/1996EP0725638A1 Treatment of laminitis
08/14/1996EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
08/14/1996EP0725629A1 Liposomal defensins
08/14/1996EP0595794B1 Cloned genes which encode elam-1 and fusion proteins thereof, the protein products expressed therefrom, pharmaceutical compositions and the use thereof
08/14/1996EP0527762B1 Inhibition of allograft and concordant xenograft rejection
08/14/1996EP0464105B1 Melanin-concentrating hormones and dna for expressing the same
08/14/1996EP0396559B1 Hiv peptides, artificial hiv antigens and immunoassay kits
08/14/1996DE19505795C1 Isolation of Thuja protein fractions
08/14/1996DE19504504A1 New orally active thrombin inhibiting peptide cpds.
08/14/1996DE19504003A1 Treatment of cognitive disorders, esp. Alzheimer's disease
08/14/1996CN1129013A New growth-differentiation factor of the TGF-beta family
08/14/1996CN1129000A New compound and its prepn.
08/14/1996CN1128955A Percutaneously absorbable prepn.
08/14/1996CN1128671A Cyclosporin soft capsule composition
08/13/1996US5545806 Ransgenic non-human animals for producing heterologous antibodies
08/13/1996US5545750 Retroviral protease inhibiting compounds
08/13/1996US5545727 DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin
08/13/1996US5545726 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
08/13/1996US5545723 Amino acid sequence where valine at position 101 is replaced with phenylalanine, tyrosine, tryptophan or histidine; diplayes an antiviral activity, that is atleast partially neutralized by antibodies to wild type interferon-beta
08/13/1996US5545722 Hepatocyte-growth agent
08/13/1996US5545721 Reacting crosslinker derivatized antibiotic with crosslinker derivatized immunoglobulin to form conjugate which bonds to surface of microorganisms
08/13/1996US5545720 Protein PHBP-70
08/13/1996US5545719 Nerve growth peptides
08/13/1996US5545718 Synthetic peptides of the conjugate of ubiquitine and H2A histone
08/13/1996US5545716 Superantigen agonist and antagonist peptides
08/13/1996US5545672 Administering to inhibit production of the beta' fragment of the insulin receptor
08/13/1996US5545668 Oral glutamine to reduce stomatitis
08/13/1996US5545662 Used to accelerate recovery from neutropenia accompanying radio or chemotherapy, bone marrow transplantation, or infections
08/13/1996US5545629 5-ethoxy-2'-deoxyuridines
08/13/1996US5545621 Prodrug; controlling metabolism detoxification of cells
08/13/1996US5545620 Synthetic fibronectin fragments as inhibitors of retroviral infection
08/13/1996US5545619 Autoimmune diseases; transplant rejection, reduction in tissue damage associated with myocardial infarctions and strokes; medical diagnosis
08/13/1996US5545618 GLP-1 analogs useful for diabetes treatment
08/13/1996US5545617 Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
08/13/1996US5545616 Method for predicting and/or preventing preterm labor
08/13/1996US5545615 A method of inhibiting fertilization by alpha-1-antitrypsin or antithrombin III
08/13/1996US5545614 Controlling nitrogen oxide concentrations to modulate skeletal muscle contraction
08/13/1996US5545563 Dna molecule; anticancer agents
08/13/1996US5545551 Cloning and expression of pur protein
08/13/1996US5545549 DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
08/13/1996US5545536 Colony-stimulating factor derivatives
08/13/1996US5545532 Human carcinoma antigen (HCA), HCA antibodies, HCA immunoassays and methods of imaging
08/13/1996US5545408 Containing lutenizing hormone releasing hormone agonist
08/13/1996US5545405 Administering recombinant antibody glycosylated by chinese hamster ovary cell
08/13/1996US5545404 Method for treating a mammal suffering from a T-cell medicated disorder with a CHO-Glycosylated antibody
08/13/1996US5545403 Method for treating a mammal by administering a CHO-glycosylated antibody
08/13/1996US5545402 Skin care method and composition
08/13/1996US5545328 Purification of hemoglobin by displacement chromatography
08/13/1996CA1338518C Antibody heteroconjugates for the killing of hiv-infected cells
08/11/1996CA2169152A1 Center dispense suture package
08/08/1996WO1996024061A1 Methods and apparatus for synthesizing labeled combinatorial chemical libraries
08/08/1996WO1996023896A1 Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus
08/08/1996WO1996023889A1 Recombinant rna viral vector and method of preparing the same
08/08/1996WO1996023888A1 NOVEL c-MPL LIGANDS
08/08/1996WO1996023885A1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
08/08/1996WO1996023884A2 Human peroxisome proliferator activated receptors
08/08/1996WO1996023883A2 Modified ligands for receptor tyrosine kinases
08/08/1996WO1996023882A1 IDENTIFICATION OF DEC, (DENTRITIC AND EPITHELIAL CELLS, 205 kDa), A RECEPTOR WITH C-TYPE LECTIN DOMAINS, NUCLEIC ACIDS ENCODING DEC, AND USES THEREOF
08/08/1996WO1996023881A1 Chimeric receptors for regulating cellular proliferation and effector function
1 ... 2773 2774 2775 2776 2777 2778 2779 2780 2781 2782 2783 2784 2785 2786 2787 2788 2789 2790 2791 2792 2793 ... 3163